Showing results (11-20 of 102) with videos related to

Sort By:
Pageof 11
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 8, 2014
PSA response rate as a surrogate marker for median overall survival in docetaxel-based first-line treatments for patients with metastatic castration-resistant prostate cancer: an analysis of 22 trialsEdoardo Francini, Roberto Petrioli, Giulia Rossi, et al.
Cancer Investigation|May 8, 2015
Targeted Therapies for Prostate CancerRoberto Petrioli, Edoardo Francini, Anna Ida Fiaschi, et al.
Cancer Treatment Reviews|July 16, 2008
The role of doxorubicin and epirubicin in the treatment of patients with metastatic hormone-refractory prostate cancerRoberto Petrioli, Anna Ida Fiaschi, Edoardo Francini, et al.
Medicine|December 16, 2014
Effects of abiraterone acetate on chronic kidney disease in 2 patients with metastatic castration-resistant prostate cancerEdoardo Francini, Roberto Petrioli, Anna Ida Fiaschi, et al.
Urology|February 3, 2007
Weekly docetaxel and epirubicin in treatment of advanced hormone-refractory prostate cancerRoberto Petrioli, Loretta Paolelli, Edoardo Francini, et al.
Oncology|May 13, 2022
Risk Factors for Nab-Paclitaxel and Gemcitabine-Induced Peripheral Neuropathy in Patients with Pancreatic CancerMartina Catalano, Monica Ramello, Raffaele Conca, et al.
Scientific Reports|May 17, 2022
The impact of age, performance status and comorbidities on nab-paclitaxel plus gemcitabine effectiveness in patients with metastatic pancreatic cancerMartina Catalano, Giuseppe Aprile, Raffaele Conca, et al.
Journal of Clinical Medicine|April 30, 2021
Association between Low-Grade Chemotherapy-Induced Peripheral Neuropathy (CINP) and Survival in Patients with Metastatic Adenocarcinoma of the PancreasMartina Catalano, Giuseppe Aprile, Monica Ramello, et al.
Cancer Chemotherapy and Pharmacology|June 18, 2015
Role of chemotherapy in the treatment of metastatic castration-resistant prostate cancer patients who have progressed after abiraterone acetateRoberto Petrioli, Edoardo Francini, Letizia Laera, et al.
Investigational New Drugs|October 23, 2018
Corticosteroid switch in heavily pre-treated castration-resistant prostate cancer patients progressed on abiraterone acetate plus prednisoneGiandomenico Roviello, Roberto Petrioli, Alberto Bonetta, et al.
Pageof 11